Article Details

Phase 2 HOPE Study of PACAP-Targeting Treatment Lu AG09222 Published in ... - NeurologyLive

Retrieved on: 2024-09-13 17:07:53

Tags for this article:

Click the tags to see associated articles and topics

Phase 2 HOPE Study of PACAP-Targeting Treatment Lu AG09222 Published in ... - NeurologyLive. View article details on hiswai:

Excerpt

Lu AG09222 is a humanized monoclonal antibody delivered through intravenous infusion that binds to the PACAP ligand with high affinity, prevents PACAP ...

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo